Contraception: Your Questions Answered, 7th Edition
Authors :
John Guillebaud & Anne MacGregor
Date of Publication: 08/2017
This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods.
Combined oral contraceptives (COCs) Based on the long-es
...view more
This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods.
Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either:
Tricycling, the 84/4 regimen, or totally continuous use (365/365),
OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days
New methods, and their importance or otherwise:
Intrauterine system: Jaydess®
Subcutaneous, self-injectable alternative to Depo-Provera: Sayana® Press
This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods.
Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either:
Tricycling, the 84/4 regimen, or totally continuous use (365/365),
OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days
New methods, and their importance or otherwise:
Intrauterine system: Jaydess®
Subcutaneous, self-injectable alternative to Depo-Provera: Sayana® Press
Quick starting and bridging (the Proving not Pregnant Protocol)
Emergency contraception (EC), how advice differs for ulipristal acetate EC
Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine)
New to this edition
This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods.
Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either:
Tricycling, the 84/4 regimen, or totally continuous use (365/365),
OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days
New methods, and their importance or otherwise:
Intrauterine system: Jaydess®
Subcutaneous, self-injectable alternative to Depo-Provera: Sayana® Press
Quick starting and bridging (the Proving not Pregnant Protocol)
Emergency contraception (EC), how advice differs for ulipristal acetate EC
Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine)
Intermittent quizzes for CPD portfolio purposes
Now on ExpertConsult
Key Features
Question and answer format
Important information boxes
Unwanted side effects boxes
Frequent patient questions at the end of relevant chapters
Management advice
Follow-up advice
Comes with free e-book on ExpertConsult for the first time
Author Information
By John Guillebaud, MA, FRCSEd, FRCOG(Hon), FFSRH(Hon), FCOG(SA), Emeritus Professor of Family Planning and Reproductive Health, University College London, UK; Trustee of the Margaret Pyke Trust, Formerly Medical Director of the Margaret Pyke Family Planning Centre, London, UK; Anne MacGregor, MBBS MSc MD FFSRH MICR DIPM, Associate Specialist in Sexual and Reproductive Healthcare, Bart's Sexual Health Centre, St. Bartholomew's Hospital, London and Honorary Professor, Centre for Neuroscience and Trauma within the Blizard Institute of Cell and Molecular Science, Bart's and the London School of Medicine and Dentistry, London, UK
https://www.eu.elsevierhealth.com/contraception-your-questions-answered-9780702070006.html72224Contraception: Your Questions Answeredhttps://www.eu.elsevierhealth.com/media/catalog/product/9/7/9780702070006_3.jpg37.4949.99EURInStock/Medicine and Surgery/Obstetrics & Gynaecology/Medical Students/Clinical Medicine & Examination/Books<p>This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods. </p>
<UL>
<P>
<LI>Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new <i>norm for all users</i> of either:</li>
<P></p>
<UL>
<P>
<LI>Tricycling, the 84/4 regimen, or totally continuous use (365/365), </li>
<P></p>
<P>
<LI>OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days</li>
<P></p></ul>
<P>
<LI>New methods, and their importance or otherwise:</li>
<P></p>
<UL>
<P>
<LI>Intrauterine system: Jaydess<b>®</b> </li>
<P></p>
<P>
<LI>Subcutaneous, self-injectable alternative to Depo-Provera: Sayana<b>®</b> Press</li>
<P></p>
<P>
<LI>24/4 combined hormonal contraceptives: Zoely<b>®</b>, Eloine<b>®</li>
<P></p></b>
<P>
<LI>Diaphragm: Caya<b>®</li>
<P></p></ul></b>
<P>
<LI>Updates</li>
<P></p>
<UL>
<P>
<LI>Quick starting and bridging (<i>the Proving not Pregnant Protocol</i>)</li>
<P></p>
<P>
<LI>Emergency contraception (EC), how advice differs for ulipristal acetate EC</li>
<P></p>
<P>
<LI>Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine)</li>
<P></p></ul></ul> <p>This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods. </p>
<UL>
<P>
<LI>Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new <i>norm for all users</i> of either:</li>
<P></p>
<UL>
<P>
<LI>Tricycling, the 84/4 regimen, or totally continuous use (365/365), </li>
<P></p>
<P>
<LI>OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days</li>
<P></p></ul>
<P>
<LI>New methods, and their importance or otherwise:</li>
<P></p>
<UL>
<P>
<LI>Intrauterine system: Jaydess<b>®</b> </li>
<P></p>
<P>
<LI>Subcutaneous, self-injectable alternative to Depo-Provera: Sayana<b>®</b> Press</li>
<P></p>
<P>
<LI>24/4 combined hormonal contraceptives: Zoely<b>®</b>, Eloine<b>®</li>
<P></p></b>
<P>
<LI>Diaphragm: Caya<b>®</li>
<P></p></ul></b>
<P>
<LI>Updates</li>
<P></p>
<UL>
<P>
<LI>Quick starting and bridging (<i>the Proving not Pregnant Protocol</i>)</li>
<P></p>
<P>
<LI>Emergency contraception (EC), how advice differs for ulipristal acetate EC</li>
<P></p>
<P>
<LI>Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine)</li>
<P></p></ul></ul>00add-to-cart97807020700062017StudentBy John Guillebaud, MA, FRCSEd, FRCOG(Hon), FFSRH(Hon), FCOG(SA) and Anne MacGregor, MBBS MSc MD FFSRH MICR DIPM20187Book133w x 216happrox. 65 illustrationsElsevier42414 Aug 2017PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSBy <STRONG>John Guillebaud</STRONG>, MA, FRCSEd, FRCOG(Hon), FFSRH(Hon), FCOG(SA), Emeritus Professor of Family Planning and Reproductive Health, University College London, UK; Trustee of the Margaret Pyke Trust, Formerly Medical Director of the Margaret Pyke Family Planning Centre, London, UK; <STRONG>Anne MacGregor</STRONG>, MBBS MSc MD FFSRH MICR DIPM, Associate Specialist in Sexual and Reproductive Healthcare, Bart's Sexual Health Centre, St. Bartholomew's Hospital, London and Honorary Professor, Centre for Neuroscience and Trauma within the Blizard Institute of Cell and Molecular Science, Bart's and the London School of Medicine and Dentistry, London, UKBooksYour Questions AnsweredNoNoNoNoPlease SelectPlease SelectPlease Select
